Business Wire9d
Shionogi and Jordan’s Guardian Angels Announce First-Ever Human Drug Study for Jordan’s Syndrome, an Ultra-Rare Genetic Neurodevelopmental Disorder
The drug is also being evaluated for Fragile X syndrome (FXS), the leading cause of inherited intellectual disabilities, 3 in a pivotal Phase 2b/3 program in the U.S. Jordan’s Guardian Angels ...